Research Keyword: depression treatment

Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia

This Australian study surveyed over 500 people about their views on psychedelics like psilocybin and MDMA for treating mental health conditions. Most people supported medical legalization of these substances, though many had safety concerns. Those with mental illness, those with prior psychedelic experience, and those with better knowledge of psychedelics were most supportive of their therapeutic use.

Read More »

Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms

This study reveals that two different types of magic mushrooms—Psilocybe and Inocybe—make psilocybin (the active compound in magic mushrooms) using completely different enzymes and chemical pathways. Despite both mushroom types producing the same final product, they evolved their recipes independently, like two chefs arriving at the same dish through entirely different cooking methods. The research shows how evolution can solve the same problem in multiple ways and provides new enzymes that could be useful for producing psilocybin as a potential depression treatment.

Read More »

Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives

This review examined research on Psilocybe mushrooms and their chemical compounds, particularly psilocybin and psilocin, which show promise for treating depression and anxiety. The authors found that while these psychoactive compounds have been extensively studied, many other chemical substances in these mushrooms remain unexplored. Additionally, preliminary studies suggest these mushrooms may have antimicrobial and antioxidant properties, though more research is needed. The review highlights significant gaps in understanding the full potential of Psilocybe mushrooms for medical applications.

Read More »
Scroll to Top